Kévin Bourcier

925 total citations
15 papers, 261 citations indexed

About

Kévin Bourcier is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Kévin Bourcier has authored 15 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Kévin Bourcier's work include Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (2 papers) and Advanced Breast Cancer Therapies (2 papers). Kévin Bourcier is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (2 papers) and Advanced Breast Cancer Therapies (2 papers). Kévin Bourcier collaborates with scholars based in France and United States. Kévin Bourcier's co-authors include Axel Le Cesne, Charles Honoré, Julien Adam, Thierry de Baère, Olivier Mir, Lambros Tsélikas, Guy J. Buckle, Samia J. Khoury, Howard L. Weiner and Charles R.G. Guttmann and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Annals of Oncology.

In The Last Decade

Kévin Bourcier

12 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kévin Bourcier France 7 142 94 72 60 58 15 261
Jean-François Emile France 5 130 0.9× 150 1.6× 111 1.5× 43 0.7× 82 1.4× 11 361
Shogo Urabe Japan 9 95 0.7× 112 1.2× 38 0.5× 88 1.5× 59 1.0× 27 280
Shu-Mei Yan China 9 165 1.2× 114 1.2× 63 0.9× 32 0.5× 82 1.4× 11 290
Xiu-Yu Cai China 8 200 1.4× 69 0.7× 36 0.5× 100 1.7× 74 1.3× 9 308
Kathleen Polson United States 7 232 1.6× 248 2.6× 56 0.8× 53 0.9× 34 0.6× 9 367
Francisco Aparisi Spain 10 184 1.3× 167 1.8× 25 0.3× 36 0.6× 25 0.4× 30 297
Weihua Yin China 10 101 0.7× 72 0.8× 33 0.5× 75 1.3× 59 1.0× 25 279
Bertrand Filleul Belgium 8 69 0.5× 84 0.9× 57 0.8× 65 1.1× 33 0.6× 14 265
Miho Kawaida Japan 9 88 0.6× 100 1.1× 17 0.2× 31 0.5× 113 1.9× 33 262
Moises J. Velez United States 7 234 1.6× 114 1.2× 40 0.6× 17 0.3× 39 0.7× 14 316

Countries citing papers authored by Kévin Bourcier

Since Specialization
Citations

This map shows the geographic impact of Kévin Bourcier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kévin Bourcier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kévin Bourcier more than expected).

Fields of papers citing papers by Kévin Bourcier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kévin Bourcier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kévin Bourcier. The network helps show where Kévin Bourcier may publish in the future.

Co-authorship network of co-authors of Kévin Bourcier

This figure shows the co-authorship network connecting the top 25 collaborators of Kévin Bourcier. A scholar is included among the top collaborators of Kévin Bourcier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kévin Bourcier. Kévin Bourcier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Tourneau, Christophe Le, Sophie Cousin, Maud Toulmonde, et al.. (2023). 138P Precision medicine phase II study evaluating the efficacy of olaparib in patients with progressive solid cancers and carriers of homologous recombination repair genes alterations. Annals of Oncology. 34. S236–S236. 2 indexed citations
3.
Cousin, Sophie, Coralie Cantarel, Jean‐Philippe Guégan, et al.. (2022). Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial. European Journal of Cancer. 162. 161–169. 35 indexed citations
4.
5.
6.
Cousin, Sophie, Carine Bellera, Jean‐Philippe Guégan, et al.. (2021). Regomune: A phase II study of regorafenib + avelumab in solid tumors—Results of the biliary tract cancer (BTC) cohort.. Journal of Clinical Oncology. 39(15_suppl). 4096–4096. 7 indexed citations
7.
Deluche, Élise, Kévin Bourcier, F. Thuillier, et al.. (2020). CN46 Real-life experience of nurses coordinating device in oral therapy center (DICTO program). Annals of Oncology. 31. S1141–S1141.
8.
Toulmonde, Maud, Mehdi Brahmi, Antoine Giraud, et al.. (2020). LBA67 TRAMUNE, a phase Ib study combining trabectedin and durvalumab, results of the expansion cohort in patients with advanced pretreated soft tissue sarcomas. Annals of Oncology. 31. S1199–S1199. 5 indexed citations
9.
Deluche, Élise, Kévin Bourcier, Valérie Le Brun-Ly, et al.. (2020). Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme). Medical Oncology. 37(8). 69–69. 6 indexed citations
10.
Cousin, Sophie, Carine Bellera, Jean‐Philippe Guégan, et al.. (2020). REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the non-MSI-H metastatic colorectal cancer (mCRC) cohort.. Journal of Clinical Oncology. 38(15_suppl). 4019–4019. 30 indexed citations
11.
Bourcier, Kévin, Axel Le Cesne, Lambros Tsélikas, et al.. (2019). Basic Knowledge in Soft Tissue Sarcoma. CardioVascular and Interventional Radiology. 42(9). 1255–1261. 78 indexed citations
12.
Bourcier, Kévin, Axel Le Cesne, Charles Honoré, et al.. (2019). Outcome of Patients with Soft-Tissue Sarcomas: An Age-Specific Conditional Survival Analysis. The Oncologist. 24(7). e559–e564. 4 indexed citations
13.
Bourcier, Kévin & Antoîne Italiano. (2018). Newer therapeutic strategies for soft-tissue sarcomas. Pharmacology & Therapeutics. 188. 118–123. 6 indexed citations
14.
Bourcier, Kévin, V. Fermeaux, Sophie Léobon, & Élise Deluche. (2018). Lobular Breast Carcinoma Metastasis to the Thyroid Gland: Case Report and Literature Review. Journal of Breast Cancer. 21(4). 463–463. 8 indexed citations
15.
Viglietta, Vissia, Kévin Bourcier, Guy J. Buckle, et al.. (2008). CTLA4Ig treatment in patients with multiple sclerosis. Neurology. 71(12). 917–924. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean-François Emile Breakdown of academic impact, for papers by Shogo Urabe Breakdown of academic impact, for papers by Shu-Mei Yan Breakdown of academic impact, for papers by Xiu-Yu Cai Breakdown of academic impact, for papers by Kathleen Polson Breakdown of academic impact, for papers by Francisco Aparisi Breakdown of academic impact, for papers by Weihua Yin Breakdown of academic impact, for papers by Bertrand Filleul Breakdown of academic impact, for papers by Miho Kawaida Breakdown of academic impact, for papers by Moises J. Velez
Rankless by CCL
2026